Answers are grounded in this paper and cite their sources.
BACKGROUND: Second-look US emerged as a feasible tool to evaluate MRI-detected lesions, although data regarding the accuracy and optimal lesion selection for second-look US is limited. Therefore, we evaluated the second-look US detection rate of breast lesions detected initially on MRI by using MRI features and compared second-look US findings across benign and malignant lesions. MATERIAL AND METHODS: A total of 110 MRI-detected lesions subsequently evaluated with the second-look US were retrospectively reviewed. The performance of MRI features in the prediction of second-look US detection was evaluated with ROC analyses. RESULTS: The positive and negative predictive values of second-look US for malignancy detection were 28.8% and 96.1%, respectively. In multivariate analyses, the MRI BI-RADS category (OR: 11.896, p < 0.001) and lesion type (OR: 9.470, p = 0.001) were significantly associated with second-look US detection. Combined scoring with these factors could predict second-look US detection [AUC: 0.712, 95% CI: 0.617-0.807 p < 0.001]. Furthermore, lesions with irregular shapes and margins were more often malignant in the analysis of US findings (p < 0.001). CONCLUSIONS: The MRI BI-RADS category and lesion type could predict detection in the second-look US for MRI-detected lesions. Besides, second-look US could give additional information to distinguish between benign and malignant masses.
No takes yet. Share an insight, caveat, or question.
Güven et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: